Cholinergic system and constructional praxis: a further study of physostigmine in Alzheimer's disease - Wikidata - wikimedia - TriplyDB

Cholinergic system and constructional praxis: a further study of physostigmine in Alzheimer's disease

Cholinergic system and constructional praxis: a further study of physostigmine in Alzheimer's disease

http://www.wikidata.org/entity/Q33619760

about

Physostigmine for Alzheimer's disease.Clinical trials in Alzheimer's disease. A report from the Medical Research Council Alzheimer's Disease Clinical Trials Committee Beneficial effect of physostigmine on clinical amnesic behaviour and neuropsychological test results in a patient with a post-encephalitic amnesic syndrome.Chronic oral physostigmine without lecithin improves memory in Alzheimer's disease.Sensitivity of age-decline resistant ("hold") WAIS subtests to Alzheimer's disease.The cholinergic neurotransmitter system in human memory and dementia: a review.Pharmacotherapy of cognitive impairment in Alzheimer's disease: a review.Memory related role of the posterior cholinergic system.Effect of the putative cognitive enhancer, linopirdine (DuP 996), on quantal parameters of acetylcholine release at the frog neuromuscular junction.Equivalent spatial-rotation deficits in normal aging and Alzheimer's disease.Clinical studies of the cholinergic deficit in Alzheimer's disease. II. Psychopharmacologic studies.Cholinergic effects on constructional abilities and on mnemonic processes: a case report

P2860

Q33423337-00972053-3950-4E86-976F-FE72E600ED83 Q33589344-5E6656BC-4DD9-4754-8D47-75759256974F Q33622652-5E640358-AC6B-433A-A0AE-008F883A28F0 Q38596419-40A44A5E-CC97-4547-97B6-9EBDD094BFD7 Q39238547-ADC4F5ED-1055-4169-AB5E-46F4816578F7 Q39756011-045012F5-906F-41A4-A0B2-2B718DD13DD6 Q40552135-026BFDED-16FC-4B15-B9B8-852D3DF0BC05 Q42661337-6CD3DBB0-026A-4CA1-859B-AC8C364C842C Q42701967-A42CB3CC-097B-4A9E-81F6-551293B1929E Q52069394-F967624C-214D-4474-A69F-77E78449AB2A Q52204857-2CEE7A1E-76FA-480B-81DE-56B1B130E733 Q57913275-DEDE4E87-926E-4A86-9953-195D8C396E24

P2860

Cholinergic system and constructional praxis: a further study of physostigmine in Alzheimer's disease

http://www.wikidata.org/entity/Q33619760

description

1984 nî lūn-bûn

@nan

1984 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1984 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1984年の論文

@ja

1984年論文

@yue

1984年論文

@zh-hant

1984年論文

@zh-hk

1984年論文

@zh-mo

1984年論文

@zh-tw

1984年论文

@wuu

name

Cholinergic system and constru ...... tigmine in Alzheimer's disease

@ast

Cholinergic system and constru ...... tigmine in Alzheimer's disease

@en

type

label

Cholinergic system and constru ...... tigmine in Alzheimer's disease

@ast

Cholinergic system and constru ...... tigmine in Alzheimer's disease

@en

prefLabel

Cholinergic system and constru ...... tigmine in Alzheimer's disease

@ast

Cholinergic system and constru ...... tigmine in Alzheimer's disease

@en

P1433

Q33619760-941C0217-9AE4-46ED-B9A2-34D8CC570200

P1476

Q33619760-F8A93AE8-9C49-4960-9BDE-CF179373D18F

P2093

Q33619760-2F532B5A-D075-4D50-8002-11564BEEFE0A

Q33619760-46E57988-EFF7-460C-8D8A-0D5A640DC6F1

Q33619760-48CFE284-58E6-419E-94F3-74829E11190B

P2860

Q33619760-03873D87-34AB-4F9C-8ADD-89A3F436476C

Q33619760-0E54D16B-95B3-4125-BC53-EC96CD16F6FC

Q33619760-27B89741-2BFC-4820-B467-E4404B165AD9

Q33619760-348E0247-31EC-4099-ADF3-A42343D87A50

Q33619760-5F5A80D3-9A54-4748-95E6-68E546EE6260

Q33619760-85CECF30-E089-4309-A577-8B7A18FBFB49

Q33619760-932F1424-51AB-4849-844F-393795FCBB9F

Q33619760-A7188A8C-897A-42B1-88A4-6C5828CF9956

Q33619760-B26180C5-E085-4CB9-84C1-E53622470C89

Q33619760-B5437FDC-15B7-48D5-9082-BD7838EE03A5

P304

Q33619760-9BFCB9BA-D726-4DFA-9A03-D07C891D6150

P31

Q33619760-CD4A9C85-1862-4035-A603-E5DB316E2A47

P356

Q33619760-1FC5CDFC-85DF-4946-B448-5DF8AA78AE5D

P407

Q33619760-70F3D74B-CBAE-4A4E-A1C4-872E23521CC7

P433

Q33619760-F0B04224-35CE-4EAB-BEBE-5F4736CFBA01

P478

Q33619760-1CCDBA3A-58EC-4924-AE76-1FF5945E43E3

P577

Q33619760-86B93EB1-4077-4639-A93F-CF932EB8F0D0

P5875

Q33619760-1722A817-D05E-4C80-B0F8-AD6FD38F0668

P698

Q33619760-9A474FA4-D85B-4E78-841F-44E4460FF5A6

P921

Q33619760-593C86A7-41D9-488A-87AA-F68ED9520ECF

P932

Q33619760-C8709AA9-731F-454C-9957-AE3C0735527F

P356

P1433

Journal of Neurology, Neurosurgery and Psychiatry

P1476

Cholinergic system and constru ...... tigmine in Alzheimer's disease

@en

P2093

Ando K

http://www.w3.org/2001/XMLSchema#string

Muramoto O

http://www.w3.org/2001/XMLSchema#string

Sugishita M

http://www.w3.org/2001/XMLSchema#string

P2860

Physostigmine and arecoline: effects of intravenous infusions in Alzheimer presenile dementia

Cerebral blood flow in dementia.

Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies.

Memory enhancement after physostigmine treatment in the amnesic syndrome.

Basal forebrain and hypothalamic connection to frontal and parietal cortex in the Rhesus monkey.

Physostigmine: effects on cognition and affect in normal subjects.

Selective loss of central cholinergic neurons in Alzheimer's disease.

Acetylcholinesterase-rich projections from the basal forebrain of the rhesus monkey to neocortex.

Intrusions as a sign of Alzheimer dementia: chemical and pathological verification.

Use of THA in treatment of Alzheimer-like dementia: pilot study in twelve patients.

P304

485-491

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JNNP.47.5.485

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P577

1984-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

16461972

http://www.w3.org/2001/XMLSchema#string

P698

6736979

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

1027824

http://www.w3.org/2001/XMLSchema#string